CYTKCytokinetics, Incorporated
$62.93+29% 1Y
$62.93
$47.8352 weeks$84.88
Is the price fair?
What CYTK's price assumes
Cytokinetics, Incorporated did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 162× revenue.
162
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 149
EV / sales
Details›
- EV / EBIToperating margin −1046%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 149
- Market capitalisation
- $11.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks